Global contract packaging organisation (CPO), Tjoapack, has partnered with UK-based technology company, Veratrak, to establish the use of blockchain across the pharmaceutical industry.
The partnership will include a number of projects that focus on using the properties of blockchain to enable transparent collaboration across multiple pharmaceutical supply chain partners, reducing service lead times, and driving information sharing through a secure digital chain.
The first project, which is due to be rolled out in Q4 2018, will secure and optimise the data sharing processes involved in setting up stock keeping units (SKUs) ready for packaging from product master data to artwork.
Blockchain allows data to be stored as part of an immutable ledger assuring that it cannot be altered or tampered with. Veratrak’s new document collaboration platform uses blockchain technology to allow secure data sharing across the pharmaceutical industry.
To date, blockchain technology has been explored by pharmaceutical companies through either proof of concepts (POC) or pilot projects. Veratrak has been built according to GAMP5 guidelines and is compliant with FDA part 11 regulations, making it the first global application of blockchain in a GxP environment working with multiple organisations in the supply chain.
Tjoapack will be the first user of the platform and will use its pharmaceutical expertise to ensure the Veratrak system is tailored to the industry’s challenges and that the solution is tested by an experienced supply chain partner.
Tjoapack is as a pharmaceutical contract packaging company that provides packaging solutions for customers in Europe and internationally. It specializes in the production of hospital packaging, patient-compliant packaging, and other smart packaging solutions. The company works with pharmaceutical, biotech, and med-tech industries, as well as hospitals and pharmacists. Tjoapack was founded in 1989 and is based in Etten-Leur (Netherlands).